References
- Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388–398. doi: 10.1038/s41575-023-00759-2.
- Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–2666. doi: 10.1016/j.cgh.2019.07.060.
- Kraglund F, Deleuran T, Askgaard G, et al. Decreasing incidence of alcohol-related liver disease in Denmark: a 25-year nationwide study. Clin Epidemiol. 2021;13:1–11. doi: 10.2147/CLEP.S287870.
- Williams R, Aithal G, Alexander GJ, et al. Unacceptable failures: the final report of the lancet commission into liver disease in the UK. Lancet. 2020;395(10219):226–239. doi: 10.1016/S0140-6736(19)32908-3.
- Sahlman P, Nissinen M, Pukkala E, et al. Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study. Scand J Gastroenterol. 2016;51(8):961–966. doi: 10.3109/00365521.2016.1157889.
- Wang WJ, Xiao P, Xu HQ, et al. Growing burden of alcoholic liver disease in China: a review. World J Gastroenterol. 2019;25(12):1445–1456. doi: 10.3748/wjg.v25.i12.1445.
- Smart RG. Recent international reductions and increases in liver cirrhosis deaths. Alcohol Clin Exp Res. 1988;12(2):239–242. doi: 10.1111/j.1530-0277.1988.tb00187.x.
- Gunnarsdottir SA, Olsson R, Olafsson S, et al. Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand J Gastroenterol. 2009;44(8):984–993. doi: 10.1080/00365520902912571.
- Tyrfingsson T, Olafsson S, Bjornsson ES, et al. Alcohol consumption and liver cirrhosis mortality after lifting ban on beer sales in country with state alcohol monopoly. Eur J Public Health. 2015;25(4):729–731. doi: 10.1093/eurpub/cku127.
- Thórsson B, Aspelund T, Harris TB, et al. Trends in body weight and diabetes in forty years in Iceland. Laeknabladid. 2009;95(4):259–266.
- Olafsson S, Tyrfingsson T, Runarsdottir V, et al. Treatment as prevention for hepatitis C (TraP hep C) – a nationwide elimination programme in Iceland using direct-acting antiviral agents. J Intern Med. 2018;283(5):500–507. doi: 10.1111/joim.12740.
- Olafsson S, Rögnvaldsson S, Bergmann OM, et al. A nationwide population-based prospective study of cirrhosis in Iceland. JHEP Rep. 2021;3(3):100282. doi: 10.1016/j.jhepr.2021.100282.
- Olafsson S, Fridriksdottir RH, Love TJ, et al. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study. Lancet Gastroenterol Hepatol. 2021;6(8):628–637. doi: 10.1016/S2468-1253(21)00137-0.
- Johannesson JM, Fridriksdottir RH, Löve TJ, et al. High rate of hepatitis C virus reinfection among recently injecting drug users: results from the TraP hep C program-A prospective nationwide, population-based study. Clin Infect Dis. 2022;75(10):1732–1739. doi: 10.1093/cid/ciac272.
- Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48(5):835–847. doi: 10.1016/j.jhep.2008.02.008.
- Age-standardised mortality rate calculation template, 1976. ESP Office for National Statistics.
- Boyle P, Parkin DM. Cancer registration: principles and methods. IARC Sci Publ. 1991:(95):126–158.
- Alexander N. What’s more general than a whole population? Emerg Themes Epidemiol. 2015;12(1):11. doi: 10.1186/s12982-015-0029-4.
- Björnsson ES, Johannsson A, Sigurdarson SS, et al. Development of severe alcohol related liver disease over four decades in Iceland: impact of increased access and use of alcohol. Scand J Gastroenterol. 2023;58(12):1523–1533.
- Nilsson E, Anderson H, Sargenti K, et al. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year population-based study. Aliment Pharmacol Ther. 2016;43(12):1330–1339. doi: 10.1111/apt.13635.
- Haukeland JW, Lorgen I, Schreiner LT, et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol. 2007;42(12):1501–1508. doi: 10.1080/00365520701478014.
- Fialla AD, de Muckadell OBS, Touborg Lassen A. Incidence, etiology and mortality of cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2012;47(6):702–709. doi: 10.3109/00365521.2012.661759.
- Lúdvíksdóttir D, Skúlason H, Jakobsson F, et al. Epidemiology of liver cirrhosis morbidity and mortality in Iceland. Eur J Gastroenterol Hepatol. 1997;9(1):61–66. doi: 10.1097/00042737-199701000-00015.
- Vaz J, Eriksson B, Strömberg U, et al. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. BMC Gastroenterol. 2020;20(1):84. doi: 10.1186/s12876-020-01239-6.
- Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–735. doi: 10.1016/j.jhep.2018.05.011.